Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ten-year follow-up of a randomized controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia.
Eggen CAM, Alozai T, Pronk P, Mooij MC, Gaastra MTW, Ünlü Ç, Schreve MA, van Vlijmen CJ. Eggen CAM, et al. Among authors: alozai t. J Vasc Surg Venous Lymphat Disord. 2022 May;10(3):646-653.e1. doi: 10.1016/j.jvsv.2021.08.008. Epub 2021 Aug 25. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 34450354 Clinical Trial.
A multicenter, randomized, dose-finding study of mechanochemical ablation using ClariVein and liquid polidocanol for great saphenous vein incompetence.
Lam YL, Alozai T, Schreve MA, de Smet AAEA, Vahl AC, Nagtzaam I, Lawson JA, Nieman FHM, Wittens CHA. Lam YL, et al. Among authors: alozai t. J Vasc Surg Venous Lymphat Disord. 2022 Jul;10(4):856-864.e2. doi: 10.1016/j.jvsv.2021.10.016. Epub 2021 Nov 12. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 34781008 Clinical Trial.
A comparison of patient-reported outcome measures following technical success and technical failure in the treatment of great saphenous vein incompetence using ClariVein: A subanalysis of a multicenter randomized controlled trial comparing 2% and 3% polidocanol.
Alozai T, Lam YL, Schreve MA, de Smet AA, Vahl AC, Terlouw-Punt LC, Ünlü Ç, Wittens CH. Alozai T, et al. Phlebology. 2023 Sep;38(8):532-539. doi: 10.1177/02683555231189414. Epub 2023 Jul 12. Phlebology. 2023. PMID: 37436708 Clinical Trial.